IP Verse

Injection Devices Comprising A Composition Of Hyaluronic Acid And Mepivacaine Hydrochloride

Patent No. EP3574901 (titled "Injection Devices Comprising A Composition Of Hyaluronic Acid And Mepivacaine Hydrochloride") was filed by Teoxane on Jul 29, 2014. The application was issued on Jan 26, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
LABORATOIRES VIVACYOct 26, 2022TRIPOZ

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3574901

TEOXANE
Application Number
EP19180298A
Filing Date
Jul 29, 2014
Status
Granted And Under Opposition
Dec 24, 2021
Publication Date
Jan 26, 2022
External Links
Slate, Register , Google Patents